OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A multimodal study of a first episode psychosis cohort: potential markers of antipsychotic treatment resistance
Kun Yang, Luisa Longo, Zui Narita, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 2, pp. 1184-1191
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

DRESIS: the first comprehensive landscape of drug resistance information
Xiuna Sun, Yintao Zhang, Hanyang Li, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D1263-D1275
Open Access | Times Cited: 56

Neuroimaging in schizophrenia: A review article
Mona Dabiri, Fatemeh Dehghani Firouzabadi, Kun Yang, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 43

Longitudinal changes in brain metabolites in healthy controls and patients with first episode psychosis: a 7-Tesla MRS study
Min Wang, Peter B. Barker, Nicola G. Cascella, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 5, pp. 2018-2029
Open Access | Times Cited: 24

A whole-brain neuromark resting-state fMRI analysis of first-episode and early psychosis: Evidence of aberrant cortical-subcortical-cerebellar functional circuitry
Kyle M. Jensen, Vince D. Calhoun, Zening Fu, et al.
NeuroImage Clinical (2024) Vol. 41, pp. 103584-103584
Open Access | Times Cited: 7

Response rates to sequential trials of antipsychotic medications according to algorithms or treatment guidelines in psychotic disorders. A systematic review and meta-analysis
Brian O’Donoghue, Francesco Piacenza, Helena Plapp, et al.
Schizophrenia Research (2024) Vol. 268, pp. 193-204
Open Access | Times Cited: 7

Is There a Glutathione Centered Redox Dysregulation Subtype of Schizophrenia?
Lena Palaniyappan, Min Tae M Park, Peter Jeon, et al.
Antioxidants (2021) Vol. 10, Iss. 11, pp. 1703-1703
Open Access | Times Cited: 36

Schizophrenia Increases Variability of the Central Antioxidant System: A Meta-Analysis of Variance From MRS Studies of Glutathione
Lena Palaniyappan, Priyadharshini Sabesan, Xuan Li, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 20

Olfactory neuronal cells as a promising tool to realize the “druggable genome” approach for drug discovery in neuropsychiatric disorders
Marina Mihaljević, Max Lam, Carlos A. Ayala‐Grosso, et al.
Frontiers in Neuroscience (2023) Vol. 16
Open Access | Times Cited: 7

Sex-specific involvement of the Notch–JAG pathway in social recognition
Hanna Jaaro-Peled, Melissa A. Landek‐Salgado, Nicola G. Cascella, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11

Central Oxidative Stress and Early Vocational Outcomes in First Episode Psychosis: A 7-Tesla Magnetic Resonance Spectroscopy Study of Glutathione
Michael Mackinley, Sabrina D. Ford, Peter Jeon, et al.
Schizophrenia Bulletin (2022) Vol. 48, Iss. 4, pp. 921-930
Open Access | Times Cited: 10

Ultra-high field neuroimaging in psychosis: A narrative review
Katie M. Lavigne, Kesavi Kanagasabai, Lena Palaniyappan
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 8

Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk
L. Prohens, Natàlia Rodríguez, Àlex-González Segura, et al.
Psychiatry Research (2024) Vol. 332, pp. 115722-115722
Open Access | Times Cited: 1

Reduction of N-acetyl aspartate (NAA) in association with relapse in early-stage psychosis: a 7-Tesla MRS study
Marina Mihaljević, Yu-Ho Chang, Ashley M Witmer, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1

Neuroimaging alterations and relapse in early-stage psychosis
Marina Mihaljević, Anisha Nagpal, Semra Etyemez, et al.
Journal of Psychiatry and Neuroscience (2024) Vol. 49, Iss. 2, pp. E135-E142
Open Access | Times Cited: 1

Multimodal prediction of the need of clozapine in treatment resistant schizophrenia; a pilot study in first-episode psychosis
Jonatan M. Panula, Athanasios Gotsopoulos, Jussi Alho, et al.
Biomarkers in Neuropsychiatry (2024) Vol. 11, pp. 100102-100102
Open Access | Times Cited: 1

Leveraging ultra-high field (7T) MRI in psychiatric research
Finnegan J. Calabro, Ashley C. Parr, Valerie J. Sydnor, et al.
Neuropsychopharmacology (2024) Vol. 50, Iss. 1, pp. 85-102
Closed Access | Times Cited: 1

Olfactory dysfunction and face processing of social cognition in first-episode psychosis
Semra Etyemez, Zui Narita, Marina Mihaljević, et al.
Neuroscience Research (2021) Vol. 176, pp. 79-84
Closed Access | Times Cited: 10

Dysfunction of mitochondria and GABAergic interneurons in the anterior cingulate cortex of individuals with schizophrenia
Mari Kondo, Alexis L. Norris, Kun Yang, et al.
Neuroscience Research (2022) Vol. 185, pp. 67-72
Open Access | Times Cited: 6

The impact of the UK COVID-19 pandemic on patient-reported health outcomes after stroke: a retrospective sequential comparison
Hatice Özkan, Gareth Ambler, Gargi Banerjee, et al.
Journal of Neurology (2021) Vol. 269, Iss. 4, pp. 1741-1750
Open Access | Times Cited: 6

Paradigm shift on the concept of schizophrenia that matches with both academic and clinical needs
Akira Sawa, Kun Yang, Nicola G. Cascella
Schizophrenia Research (2022) Vol. 242, pp. 123-125
Open Access | Times Cited: 4

Macro- and Micro-Structural Alterations in the Midbrain in Early Psychosis
Zicong Zhou, Kylie Jones, Elena I. Ivleva, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Lack of Efficacy of Simvastatin Adjunctive Therapy for Patients with Schizophrenia: A Meta-Analysis of Randomized Controlled Trials
Junyu Chen, Yu‐Pei Yuan, Ying Hu, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 1667-1675
Open Access

A redux of schizophrenia research in 2021
Satish Suhas, Urvakhsh Meherwan Mehta
Schizophrenia Research (2022) Vol. 243, pp. 458-461
Open Access | Times Cited: 1

Human olfactory neuronal cells through nasal biopsy: molecular characterization and utility in brain science
Kun Yang, Koko Ishizuka, Andrew P. Lane, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top